These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


397 related items for PubMed ID: 7801200

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Juvenile dermatomyositis].
    Martini A, Ravelli A, Aramini L, Ramenghi B.
    Pediatr Med Chir; 1990; 12(6):587-91. PubMed ID: 2093879
    [Abstract] [Full Text] [Related]

  • 4. Age-dependent inhibition of ectopic calcification: a possible role for fetuin-A and osteopontin in patients with juvenile dermatomyositis with calcinosis.
    Marhaug G, Shah V, Shroff R, Varsani H, Wedderburn LR, Pilkington CA, Brogan PA.
    Rheumatology (Oxford); 2008 Jul; 47(7):1031-7. PubMed ID: 18448482
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Clinical analysis of 11 cases of juvenile dermatomyositis and polymyositis].
    Ito S, Miyamae T, Imagawa T, Katakura S, Mori M, Tomono J, Ibe M, Mituda T, Aihara Y, Yokota S.
    Ryumachi; 1998 Dec; 38(6):785-92. PubMed ID: 10047716
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Complete and sustained resolution of calcinosis universalis in a juvenile dermatomyositis case with mycophenolate mofetil.
    Çakan M, Karadağ ŞG, Ayaz NA.
    Turk J Pediatr; 2019 Dec; 61(5):771-775. PubMed ID: 32105011
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Calcinosis in juvenile dermatomyositis: a possible role for the vitamin K-dependent protein matrix Gla protein.
    van Summeren MJ, Spliet WG, van Royen-Kerkhof A, Vermeer C, Lilien M, Kuis W, Schurgers LJ.
    Rheumatology (Oxford); 2008 Mar; 47(3):267-71. PubMed ID: 18234711
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy of probenecid for a patient with juvenile dermatomyositis complicated with calcinosis.
    Nakamura H, Kawakami A, Ida H, Ejima E, Origuchi T, Eguchi K.
    J Rheumatol; 2006 Aug; 33(8):1691-3. PubMed ID: 16881125
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Bisphosphonates in juvenile dermatomyositis with dystrophic calcinosis.
    Tayfur AC, Topaloglu R, Gulhan B, Bilginer Y.
    Mod Rheumatol; 2015 Jul; 25(4):615-20. PubMed ID: 25800510
    [Abstract] [Full Text] [Related]

  • 19. The arthritis of inflammatory childhood myositis syndromes.
    Tse S, Lubelsky S, Gordon M, Al Mayouf SM, Babyn PS, Laxer RM, Silverman ED, Schneider R, Feldman BM.
    J Rheumatol; 2001 Jan; 28(1):192-7. PubMed ID: 11196524
    [Abstract] [Full Text] [Related]

  • 20. Treatment of Calcinosis in Juvenile Dermatomyositis.
    Kul Cinar O, Papadopoulou C, Pilkington CA.
    Curr Rheumatol Rep; 2021 Feb 08; 23(2):13. PubMed ID: 33555459
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.